Which drug should be avoided in hypotensive patients?

Which drug should be avoided in hypotensive patients?

• A. Acepromazine
• B. Dexmedetomidine
• C. Ketamine
• D. Propofol

Answer: (A)

In hypotensive patients, avoid drugs that lower blood pressure further. Acepromazine does this reliably because it blocks alpha-1 receptors on vascular smooth muscle. That blocks the normal vasoconstrictive response, causing significant arterial and venous dilation, which drops systemic vascular resistance and venous return. The result is a fall in blood pressure and a blunted compensatory response (like tachycardia), so in someone who is already hypotensive, acepromazine can push them into decompensation. It’s a classic contraindication in low BP because the vasodilatory effect is predictable and hard to offset. Dexmedetomidine can lower BP and slow the heart, but its effects are more variable: it may cause initial peripheral vasoconstriction and a transient rise in blood pressure, followed by bradycardia and hypotension as the central sympatholysis dominates. Because of this mixed profile, it’s used with caution and close monitoring rather than being categorically avoided. Ketamine, in contrast, tends to support blood pressure and heart rate by stimulating sympathetic activity and preserving cardiac output, making it safer for patients with low blood pressure in many scenarios. Propofol also reduces blood pressure through vasodilation and myocardial depression, but it can still be used carefully with fluids and vasopressors. However, it remains a concern in hypotensive patients because it can quickly worsen hemodynamics. So the drug most clearly avoided in hypotensive patients is acepromazine due to its pronounced and predictable vasodilatory effect that can markedly lower blood pressure.

In hypotensive patients, avoid drugs that lower blood pressure further. Acepromazine does this reliably because it blocks alpha-1 receptors on vascular smooth muscle. That blocks the normal vasoconstrictive response, causing significant arterial and venous dilation, which drops systemic vascular resistance and venous return. The result is a fall in blood pressure and a blunted compensatory response (like tachycardia), so in someone who is already hypotensive, acepromazine can push them into decompensation. It’s a classic contraindication in low BP because the vasodilatory effect is predictable and hard to offset.

Dexmedetomidine can lower BP and slow the heart, but its effects are more variable: it may cause initial peripheral vasoconstriction and a transient rise in blood pressure, followed by bradycardia and hypotension as the central sympatholysis dominates. Because of this mixed profile, it’s used with caution and close monitoring rather than being categorically avoided.

Ketamine, in contrast, tends to support blood pressure and heart rate by stimulating sympathetic activity and preserving cardiac output, making it safer for patients with low blood pressure in many scenarios.

Propofol also reduces blood pressure through vasodilation and myocardial depression, but it can still be used carefully with fluids and vasopressors. However, it remains a concern in hypotensive patients because it can quickly worsen hemodynamics.

So the drug most clearly avoided in hypotensive patients is acepromazine due to its pronounced and predictable vasodilatory effect that can markedly lower blood pressure.